Lifestance Health [LFST] vs Chemed [CHE] Detailed Stock Comparison

Lifestance Health Group Inc.

NASDAQ
Loading...

Chemed Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Lifestance Health Group Inc. wins in 5 metrics, Chemed Corporation wins in 15 metrics, with 0 ties. Chemed Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Lifestance Health Group Inc. Chemed Corporation Better
P/E Ratio (TTM) 345.25 20.88 Chemed Corporation
Price-to-Book Ratio 1.76 5.36 Lifestance Health Group Inc.
Debt-to-Equity Ratio 31.20 14.68 Chemed Corporation
PEG Ratio 18.06 -2.12 Lifestance Health Group Inc.
EV/EBITDA 36.53 13.21 Chemed Corporation
Profit Margin (TTM) 0.68% 10.48% Chemed Corporation
Operating Margin (TTM) 4.74% 16.62% Chemed Corporation
EBITDA Margin (TTM) 4.74% 16.62% Chemed Corporation
Return on Equity 0.65% 25.28% Chemed Corporation
Return on Assets (TTM) 0.73% 13.40% Chemed Corporation
Free Cash Flow (TTM) $110.03M $325.48M Chemed Corporation
Dividend Yield N/A 0.56% N/A
1-Year Return 29.80% -25.82% Lifestance Health Group Inc.
Price-to-Sales Ratio (TTM) 1.86 2.03 Lifestance Health Group Inc.
Enterprise Value $2.92B $5.34B Chemed Corporation
EV/Revenue Ratio 2.05 2.11 Lifestance Health Group Inc.
Gross Profit Margin (TTM) 33.04% 35.22% Chemed Corporation
Revenue per Share (TTM) $4 $176 Chemed Corporation
Earnings per Share (Diluted) $0.02 $18.34 Chemed Corporation
Beta (Stock Volatility) 1.13 0.48 Chemed Corporation
Short % of Float 8.99% 4.26% Chemed Corporation

Lifestance Health Group Inc. vs Chemed Corporation Stock Performance Analysis

Loading Price Chart...

LFST
CHE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lifestance Health Group Inc.-3.35%-1.45%3.16%3.16%17.19%7.76%
Chemed Corporation2.31%-2.86%0.22%0.64%-0.92%0.72%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lifestance Health Group Inc.29.80%-8.87%-67.88%-67.88%-67.88%-67.88%
Chemed Corporation-25.82%-21.43%-14.46%221.65%544.03%685.29%

Performance & Financial Health Analysis: Lifestance Health Group Inc. vs Chemed Corporation

MetricLFSTCHE
Market Information
Market Cap i$2.68B$5.65B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,160,576222,026
90 Day Avg. Volume i1,708,069264,265
Last Close$7.50$426.86
52 Week Range$3.74 - $8.89$365.21 - $570.34
% from 52W High-15.64%-25.16%
All-Time High$29.81 (Jul 05, 2021)$654.62 (Mar 11, 2024)
% from All-Time High-74.84%-34.79%
Growth Metrics
Quarterly Revenue Growth0.17%0.00%
Quarterly Earnings GrowthN/A-0.15%
Financial Health
Profit Margin (TTM) i0.01%0.10%
Operating Margin (TTM) i0.05%0.17%
Return on Equity (TTM) i0.01%0.25%
Debt to Equity (MRQ) i31.2014.68
Cash & Liquidity
Book Value per Share (MRQ)$3.92$71.44
Cash per Share (MRQ)$0.64$5.41
Operating Cash Flow (TTM) i$146.15M$388.27M
Levered Free Cash Flow (TTM) i$112.90M$246.01M
Dividends
Last 12-Month Dividend Yield iN/A0.56%
Last 12-Month Dividend iN/A$2.30

Valuation & Enterprise Metrics Analysis: Lifestance Health Group Inc. vs Chemed Corporation

MetricLFST (Apr 24, 2026)CHE (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i345.2520.88
Forward P/E i18.0614.39
PEG Ratio i18.06-2.12
Price to Sales (TTM) i1.862.03
Price to Book (MRQ) i1.765.36
Market Capitalization
Market Capitalization i$2.68B$5.65B
Enterprise Value i$2.92B$5.34B
Enterprise Value Metrics
Enterprise to Revenue i2.052.11
Enterprise to EBITDA i36.5313.21
Risk & Other Metrics
Beta i1.130.48
Book Value per Share (MRQ) i$3.92$71.44

Financial Statements Comparison: Lifestance Health Group Inc. vs Chemed Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLFST (2025)CHE (2025)
Revenue/Sales i1.42B2.53B
Cost of Goods Sold i963.19M1.71B
COGS % of Revenue i67.6%67.5%
Gross Profit i461.10M823.18M
Gross Margin i32.4%32.5%
Research & Development iN/AN/A
Operating Income (EBIT) i24.15M341.16M
Operating Margin i1.7%13.5%
EBITDA i78.78M425.28M
EBITDA Margin i5.5%16.8%
Pre-Tax Income i12.36M355.78M
Pre-Tax Income % of Revenue i0.9%14.1%
Income Tax i2.70M90.54M
Income Tax % of Revenue i0.2%3.6%
Net Income (Profit) i9.66M265.24M
Profit Margin i0.7%10.5%

Balance Sheet & Liquidity Metrics

MetricLFST (2025)CHE (2025)
Cash & Equivalents i248.64M74.52M
Total Current Assets i416.20M302.62M
Total Current Assets % of Revenue i29.2%12.0%
Total Current Liabilities i251.96M287.13M
Total Current Liabilities % of Revenue i17.7%11.3%
Long-Term Debt i414.48M102.87M
Long-Term Debt % of Revenue i29.1%4.1%
Total Shareholders Equity i1.52B979.41M
Retained Earnings i-808.63M2.96B
Retained Earnings % of Revenue i-56.8%116.8%
Property, Plant & Equipment i150.79M131.15M

Cash Flow Statement Comparison

MetricLFST (2025)CHE (2025)
Operating Cash Flow i172.90M383.11M
Operating Cash Flow % of Revenue i12.1%15.1%
Capital Expenditures i-36.13M4.57M
Free Cash Flow i110.03M325.48M
FCF Margin i7.7%12.9%
Debt Repayment i-7.25M0
Common Stock Repurchase iN/A-431.50M

Short Interest & Institutional Ownership Analysis

MetricLFSTCHE
Shares Short i7.21M487,863
Short Ratio i2.991.62
Short % of Float i8.99%4.26%
Shares Outstanding i388.32M13.71M
Float Shares i204.39M13.53M
% Held by Insiders i4.36%1.87%
% Held by Institutions i96.18%98.39%
% Held by Public i-0.54%-0.26%

Dividend Analysis & Yield Comparison: Lifestance Health Group Inc. vs Chemed Corporation

MetricLFSTCHE
Last 12-Month Dividend iN/A$2.30
Last 12-Month Dividend Yield iN/A0.56%
3-Year Avg Annual Dividend iN/A$1.93
3-Year Avg Dividend Yield iN/A0.09%
3-Year Total Dividends iN/A$5.78
Ex-Dividend DateN/AFeb 23, 2026